ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,937,242 | +146.8% | 143,350 | +141.5% | 0.87% | +248.2% |
| Q2 2023 | $1,189,968 | +17.0% | 59,350 | 0.0% | 0.25% | -26.4% |
| Q1 2023 | $1,016,666 | -12.2% | 59,350 | 0.0% | 0.34% | -22.3% |
| Q4 2022 | $1,157,325 | +65.8% | 59,350 | +19.3% | 0.44% | +72.8% |
| Q3 2022 | $698,000 | +104.7% | 49,750 | +101.0% | 0.25% | +124.8% |
| Q2 2022 | $341,000 | – | 24,750 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,037,486 | $280,250,000 | 19.13% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $52,015,000 | 9.58% |
| Boxer Capital, LLC | 1,466,051 | $25,715,000 | 2.97% |
| Ghost Tree Capital, LLC | 600,000 | $10,524,000 | 2.75% |
| BRIDGER MANAGEMENT, LLC | 1,529,032 | $26,819,000 | 2.12% |
| Cormorant Asset Management, LP | 1,700,000 | $29,818,000 | 2.02% |
| EcoR1 Capital, LLC | 450,000 | $7,893,000 | 0.73% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,015 | $3,000,000 | 0.67% |
| Virtus ETF Advisers LLC | 17,799 | $312,000 | 0.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 290,001 | $5,087,000 | 0.46% |